Drug intelligence / Profile preview

xylitol + grapefruit seed extract

Development stage
Unknown
Lead developer
Xlear
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intranasal
01

Overview

A **combination intranasal spray** containing xylitol and grapefruit seed extract (GSE), most commonly formulated under the brand Xlear, marketed as a drug-free, over-the-counter nasal spray for symptomatic relief of congestion and as an adjunct in respiratory infections. **Xylitol** is a sugar alcohol with known antimicrobial and anti-adhesive properties against bacteria and some viruses, while **Grapefruit Seed Extract** is a citrus-derived mixture containing bioactive compounds (including flavonoids, polyphenols, organic acids), and in commercial GSE, frequently certain quaternary ammonium compounds, believed to confer broad-spectrum antimicrobial, antiviral, and antioxidant activity. The exact antiviral mechanism of this combination is not fully elucidated, but clinical case series and in vitro evidence have suggested **potential virucidal activity against enveloped respiratory viruses, including SARS-CoV-2**, possibly by reducing viral load in the nasal mucosa and limiting pathogen entry via the ACE2-rich nasal epithelium. The spray is typically used as an adjunct, not a replacement for standard of care, and marketed for mild to moderate upper respiratory symptoms. Its safety profile is generally favorable, with no serious safety issues reported in published cases[1][3].

Brand names
Xlear Nasal SprayXlear Rescue Nasal Spray
Other names
xylitol plus grapefruit seed extractxylitol & grapefruit seed extractxylitol and grapefruit seed extract
02

Targets

ACE2 (Angiotensin-converting enzyme 2)Gag (HIV-1 Gag polyprotein)

Beyond the preview

Go deeper on xylitol + grapefruit seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xylitol + grapefruit seed extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call